Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | RXFP1 | Q9HBX9 | 5/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | PORCN | Q9H237 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12584286 | 0.92 | MAPT (0.61) | MAPTRXFP1CYP1A2KDM4ETSHR | |
| SCHEMBL18166668 | 0.92 | HSD17B10 (0.64) | MAPTRXFP1CYP1A2KDM4ETSHR | |
| SCHEMBL18166612 | 0.90 | KDM4E (0.70) | MAPTRXFP1CYP1A2KDM4ETSHR | |
| SCHEMBL18166685 | 0.87 | TSHR (0.66) | MAPTRXFP1CYP1A2KDM4ETSHR | |
| SCHEMBL18166686 | 0.86 | KMT2A (0.60) | MAPTRXFP1CYP1A2KDM4ETSHR | |
| SCHEMBL18166580 | 0.85 | HSD17B10 (0.58) | MAPTRXFP1CYP1A2KDM4ETSHR | |
| SCHEMBL10114157 | 0.85 | POLB (0.60) | MAPTRXFP1CYP1A2KDM4ETSHR | |
| SCHEMBL10114670 | 0.83 | MAPT (0.82) | MAPTRXFP1CYP1A2KDM4EPORCN | |
| SCHEMBL18166568 | 0.82 | KDM4E (0.65) | MAPTRXFP1KDM4ETSHRATM | |
| SCHEMBL18166650 | 0.82 | KDM4E (0.65) | MAPTRXFP1KDM4ETSHRATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3663295-A1 | 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL | ELI LILLY AND CO. (US) | 2020-06-10 | — | — | EP | disclosed |
| EP-3184527-A1 | 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL | Hydra Biosciences, Inc. (US) | 2017-06-28 | — | — | EP | disclosed |
| EP-2170309-B1 | 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL | HYDRA BIOSCIENCES INC (US) | 2016-10-26 | — | — | EP | disclosed |